For the quarter ending 2026-03-31, HBIO made $20,755K in revenue. -$3,424K in net income. Net profit margin of -16.50%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 20,755 | 23,735 | 20,591 | 20,450 |
| Cost of revenues | 8,511 | 9,563 | 8,570 | 8,917 |
| Gross profit | 12,244 | 14,172 | 12,021 | 11,533 |
| Sales and marketing expenses | 5,335 | 5,093 | 4,613 | 4,539 |
| General and administrative expenses | 4,702 | 4,119 | 4,176 | 4,262 |
| Research and development expenses | 2,326 | 2,183 | 2,132 | 2,189 |
| Amortization of acquired intangible assets | 820 | 850 | 855 | 1,162 |
| Goodwill impairment - note 5 | 0 | 0 | 0 | 0 |
| Other operating expenses - note 2 | 235 | 217 | 48 | 200 |
| Total operating expenses | 13,418 | 12,462 | 11,824 | 12,352 |
| Operating gain | -1,174 | 1,710 | 197 | -819 |
| Interest expense | -1,728 | -2,358 | -966 | -791 |
| Loss on pension settlement - note 8 | - | 1,233* | 0 | - |
| Loss on equity securities - note 12 | - | 0* | 0 | 0 |
| Other expense, net | -405 | -1,323 | -365 | -644 |
| Total other expense | -2,133 | -4,914 | -1,331 | -1,435 |
| Loss before income taxes | -3,307 | -3,204 | -1,134 | -2,254 |
| Income tax (benefit) expense | 117 | -357 | 97 | 28 |
| Net loss | -3,424 | -2,847 | -1,231 | -2,282 |
| Basic EPS | -0.77 | -0.064 | -0.03 | -0.05 |
| Diluted EPS | -0.77 | -0.064 | -0.03 | -0.05 |
| Basic Average Shares | 4,473,000 | 44,609,000 | 44,556,000 | 44,303,000 |
| Diluted Average Shares | 4,473,000 | 44,609,000 | 44,556,000 | 44,303,000 |
HARVARD BIOSCIENCE INC (HBIO)
HARVARD BIOSCIENCE INC (HBIO)